Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Big Bets on Wuhan: United Imaging "at Full Steam" to Support Health Industry Upgrade 2020-11-17 09:12
Kangpu Biopharmaceuticals Initiates Phase Ib/IIa Clinical Trial of KPG-818 in Systemic Lupus Erythematosus 2020-11-17 09:00
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases 2020-11-17 01:09
Sofwave receives CE Medical Mark and additional key Regulatory Clearances for its Revolutionary Skin Tightening and Wrinkle Reduction Device 2020-11-17 01:00
Princ Suvarnabhumi Hospital Achieves GHA's COVID-19 Certification of Conformance for Medical Travel 2020-11-16 23:04
Covis Group Completes Acquisition of AMAG Pharmaceuticals 2020-11-16 22:43
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases 2020-11-16 21:42
Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores 2020-11-16 21:00
PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020 2020-11-16 21:00
Viatris Inc. Launches as a New Kind of Healthcare Company, Positioned to Meet the World's Evolving Healthcare Needs 2020-11-16 20:30
Harbour BioMed Will Present Results From Its Phase II Clinical Trial with Tanfanercept (HBM9036) in Patients with Moderate-to-Severe Dry Eye Disease in China at the 25th Congress of Chinese Ophthalmological Society 2020-11-16 20:17
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense 2020-11-16 20:00
KPCPEN Introduces Two Paediatric Professors to Accelerate the Preparation of COVID-19 Vaccine 2020-11-16 16:46
Gilead Sciences Announces Recipients of its First Asia HIV Research Scholar Program 2020-11-16 15:02
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate 2020-11-16 14:00
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology 2020-11-16 08:00
PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19 2020-11-16 05:00
Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center 2020-11-14 12:40
International Diabetes Federation calls for improved funding and training to help nurses tackle the global diabetes crisis 2020-11-14 08:00
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results 2020-11-14 05:10
1 606 607 608 609 610 1508